Introduction
NFATc4 structure and expression
Name | Also known as | Length (amino acids) | Mass (Da) | Identifier (Uniprot) |
---|---|---|---|---|
Isoform 1 | ID-IXL | 902 | 95,449 | Q14934-1 |
Isoform 2 | IA-IXL | 965 | 101,680 | Q14934-2 |
Isoform 3 | IA-IXi | 964 | 101,513 | Q14934-3 |
Isoform 4 | IC-IXL | 934 | 98,436 | Q14934-4 |
Isoform 5 | IC-IXi | 933 | 98,269 | Q14934-5 |
Isoform 6 | IB-IXL | 915 | 96,662 | Q14934-6 |
Isoform 7 | IB-IXi | 914 | 96,495 | Q14934-7 |
Isoform 8 | ID-IXi | 901 | 95,282 | Q14934-8 |
Isoform 9 | IE-IXL | 890 | 94,146 | Q14934-9 |
Isoform 10 | IE-IXi | 889 | 93,978 | Q14934-10 |
Isoform 11 | IA-IXS | 857 | 90,525 | Q14934-11 |
Isoform 12 | IEi-IXL | 832 | 88,270 | Q14934-12 |
Isoform 13 | IEi-IXi | 831 | 88,103 | Q14934-13 |
Isoform 14 | IC-IXS | 826 | 87,282 | Q14934-14 |
Isoform 15 | IB-IXS | 807 | 85,508 | Q14934-15 |
Isoform 16 | ID-IXS | 794 | 84,294 | Q14934-16 |
Isoform 17 | IE-IXS | 782 | 82,991 | Q14934-17 |
Isoform 18 | IEi-IXS | 724 | 77,115 | Q14934-18 |
Isoform 19 | IV-IXL | 437 | 47,373 | Q14934-19 |
Isoform 20 | IV-IXi | 436 | 47,206 | Q14934-20 |
Isoform 21 | IV-IXS | 329 | 36,219 | Q14934-21 |
Isoform 22 | VI-IXL | 190 | 20,104 | Q14934-22 |
Isoform 23 | VI-IXi | 189 | 19,937 | Q14934-23 |
Isoform 24 | VI-IXS | 82 | 8,950 | Q14934-24 |
Tissue/cell line | Expression level | References |
---|---|---|
Non-small cell lung cancer tissue (Human) | Protein | [12] |
Breast cancer cell lines (T47D, ZR-75-1) (Human) | Protein | [13] |
Breast cancer patients’ PBMC (Human) | mRNA | [14] |
Ovarian cancer cell lines (HeyA8, SKOV3) (Human) | Protein | |
Cervical cancerous cell lines (C33A, HeLa, SiHa) (Human) | Protein | [17] |
Skin cancer tissue and cell lines (Human) | Protein | |
Pancreatic cancer tissue (Mouse) | Protein | [20] |
Colon cancer cell line HT29 (Human) | Protein | [21] |
Glioblastoma (Human) | Protein | [22] |
Schwannoma (Human) | Protein | [23] |
Lung (Mouse) | Protein | [24] |
Spleen (Mouse) | Protein | [24] |
Liver (Mouse) | Protein | [24] |
Regulatory T cells (Tregs) (Human) | mRNA | [3] |
Bone marrow-derived macrophages (Mouse) | Protein | [25] |
Cardiomyocytes (Human) | Protein | [26] |
Cardiomyocytes (Mouse) | Protein | [4] |
Keratinocytes (Human) | Protein | [27] |
Adipocytes (Mouse) | Protein | [28] |
Primary hippocampal neuron (Rat) | Protein | [6] |
Skeletal muscles (Rat) | Protein | [5] |
Modulation of NFATc4 activation
Epigenetics
Post-translational modification
Enzyme | PTM | Studied sites | Verification | References |
---|---|---|---|---|
Calcineurin | Dephosphorylation | multisites | 3 | [2] |
p38 MAP kinase | Phosphorylation | Ser168, 170 | 3, 4 | |
mTOR | Phosphorylation | Ser168, 170 | 2, 3 | [35] |
MAPK7 (ERK5) | Phosphorylation | Ser168, 170 | 2, 3 | [35] |
IRAK-1 | Phosphorylation | Ser168, 170 | 3 | [40] |
JNK1/2 | Phosphorylation | Ser213, 217 | 2, 3, 4 | [41] |
CDK3 | Phosphorylation | Ser259 | 2, 3, 4 | [19] |
PKA | Phosphorylation | Ser272, 289 | 2, 3, 4 | [42] |
RSK2 | Phosphorylation | Ser289, 344, 676 | 1, 2, 3, 4 | |
PARP-1 | ADP-ribosylation | Glu418 | 1, 2, 3, 4 | [36] |
- | Ubiquitination | - | 3 | [37] |
SIRT6 | Deacetylation | - | 3 | [38] |
Interaction proteins
Protein | Co-activator/ Co-repressor | Downstream genes | References |
---|---|---|---|
AP-1 | Co-activator | IL-2, VEGF | |
CBP | Co-activator | TNFα | [46] |
ERα | Co-repressor | LCN2 | [13] |
ERα/β | Co-repressor | IL-2 | [47] |
ERα/β | Co-activator | pS2, cathepsin D | [48] |
GATA4 | Co-activator | BNP, CnAβ | |
Lipin-1 | Co-repressor | TNFα, FABP4 | [51] |
PARP-1 | Co-repressor | BNP | [36] |
PGC-1α | Co-repressor | - | [52] |
SOX10 | Co-activator | P0 | [53] |
14-3-3 | Co-repressor | ANP |
NFATc4 functions in cancer
Lung cancer
Breast cancer
Ovarian cancer
Skin cancer
Pancreatic cancer
Brain cancer
Other cancers
Gene | NFATc4 activity | Related cancer | Regulation | References |
---|---|---|---|---|
COX-2 | Promotes | Lung cancer | Cell apoptosis | |
TNFα | Promotes | - | Cell apoptosis | [68] |
pS2 | Promotes | Breast cancer | Cell growth | [48] |
cathepsin D | Promotes | Breast cancer | Cell growth | [48] |
LCN2 | Represses | Breast cancer | Cell migration | [13] |
CXCR4 | Promotes | Ovarian cancer | Tumor spheroid formation | [16] |
SOX9 | Promotes | Pancreatic cancer | Cancer initiation | [20] |
KROX20 | Activates | Schwannoma | Cell growth | |
P0 | Promotes | Schwannoma | Cell growth |